Is There Anything Like Enough?

There are already 20 or 30 companies trying to return these things from sort of lab bench to actual clinical application. The first clinical trial started, I think in 2018; this stuff is ongoing. It's all currently being developed to treat particular diseases like arthritis and age related blindness where we know that senescent cells are directly implicated. And then the next step would be, okay, let's think about 50 year olds. There's nothing perhaps wrong with a given 50 year old apart from the fact they were born 50 years ago and they accumulated loads ofsenescent cells. You're going to have a really high bar for safety on those who pop them every morning but as we accrue more evidence it